Invention Grant
US07816326B2 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
有权
硫化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
- Patent Title: Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease
- Patent Title (中): 硫化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
-
Application No.: US11733479Application Date: 2007-04-10
-
Publication No.: US07816326B2Publication Date: 2010-10-19
- Inventor: Francisco Velazquez , Stephane L. Bogen , Ashok Arasappan , Srikanth Venkatraman , F. George Njoroge , Neng-Yang Shih
- Applicant: Francisco Velazquez , Stephane L. Bogen , Ashok Arasappan , Srikanth Venkatraman , F. George Njoroge , Neng-Yang Shih
- Applicant Address: US NJ Kenilworth
- Assignee: Schering Corporation
- Current Assignee: Schering Corporation
- Current Assignee Address: US NJ Kenilworth
- Agency: Palaiyur Kalyanaraman
- Agent Serena Farquharson-Torres
- Main IPC: A61K38/05
- IPC: A61K38/05
Abstract:
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
Public/Granted literature
- US20070197448A1 SULFUR COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE Public/Granted day:2007-08-23
Information query
IPC分类:
